AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,735.00
Bid: 7,728.00
Ask: 7,730.00
Change: 55.00 (0.72%)
Spread: 2.00 (0.03%)
Open: 7,682.00
High: 7,745.00
Low: 7,673.00
Yest. Close: 7,680.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

PRESS: Scientists Demand Clarity Over Astra's Covid-19 Vaccine Trial

Wed, 23rd Sep 2020 06:57

(Alliance News) - Scientists are seeking clarity over AstraZeneca PLC's Covid-19 vaccine trial as it remains on hold in the US, while it has been restarted elsewhere, the Financial Times reported on Tuesday.

The Covid-19 vaccine trial was originally halted because a UK participant developed a serious inflammatory condition. In the US it has been on hold for almost two weeks, while trials in other countries including the UK have restarted.

According to the newspaper, neither AstraZeneca nor the US Food & Drug Administration have provided an explanation as to why the trial had not restarted.

"Regulators in each individual country determine when trials can start and they do this in their own timeframe. Companies provide the information to the regulators to enable them to make this determination. On the current US status specifically, we are continuing to work with the FDA to facilitate review of the information and the agency will decide when the US trial can resume," AstraZeneca told the FT.

Ashish Jha, dean of the school of public health at Brown University, told the FT: "Normally, companies wouldn't give out information in the middle of a trial, but this is an exceptional case and we need to have radical transparency. Otherwise, there is a risk the public will lose confidence in the whole process."

The latest poll by Pew Research shows only half of Americans now say they definitely or probably would be vaccinated at this time. That is a 21-point drop from May.

https://www.ft.com/content/06015bd9-ed4b-44ef-a243-2bd67557d2c0

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

INSIGHT-How the U.S. locked up vaccine materials other nations urgently need

By Allison Martell and Euan RochaMay 7 (Reuters) - To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.As a result, the U.S. government laid claim n...

Today 16:00

WRAPUP 1-Britain, Germany in role reversal on AstraZeneca vaccine risks

* Britain restricts AstraZeneca to people aged over 40* In Germany, all adults free to get AZ shot on doctor's advice* Germany, with eye on summer hols, shortens gap between doses* EU regulator looking at AZ on reports of neurological illnessBy Al...

Today 15:34

UPDATE 1-Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

(Adds details and background)By Khanh VuHANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot, as the country is battling a new outbreak.A 35-year-old fe...

Today 15:31

Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

HANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot.A 35-year-old female health worker in the southern province of An Giang died on Friday, one day aft...

Today 14:54

UPDATE 1-EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

(Adds details from EMA statement on other vaccines, background)May 7 (Reuters) - Europe's medicines regulator said on Friday it was reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZeneca's COVID-19 vaccine,...

Today 13:15

UPDATE 2-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviewing AstraZeneca vaccine for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA also assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (...

Today 13:15

UPDATE 3-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviews AstraZeneca shot for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (Adds BioNTe...

Today 13:15

Canada willing to discuss COVID-19 vaccine IP waiver -statement

OTTAWA, May 7 (Reuters) - Canada on Friday said that it was ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines while it also recognized the importance of protecting IP and the integral role industry played in devel...

Today 13:00

UPDATE 1-German panel to recommend J&J COVID vaccine for over-60s - Spiegel

(Adds RKI comment, background)BERLIN, May 7 (Reuters) - Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing...

Today 12:24

Germany's STIKO to recommend J&J COVID vaccine for over-60s - Spiegel

BERLIN, May 7 (Reuters) - Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing no sources.Europe's drug regu...

Today 11:58

New UK guidance on AstraZeneca will not affect rollout schedule- official

LONDON, May 7 (Reuters) - Britain's decision to advise all under 40-year-olds to take an alternative vaccine to the Oxford/AstraZeneca one will not affect the country's plan to offer a first dose to all adults by the end of July, a senior health ...

Today 11:43

UPDATE 1-Third wave of pandemic "appears to be broken" - German health minister

(Adds detail on vaccination progress, AstraZeneca decision)BERLIN, May 7 (Reuters) - The third wave of the coronavirus pandemic appears to be broken, German Health Minister Jens Spahn said on Friday, as social distancing measures and an accelerati...

Today 09:54

UPDATE 2-Germany defends AstraZeneca pivot as key to speeding vaccinations

* All adults now free to get AZ shot, on doctor's advice* Gap between doses can be as little as 4 weeks* Experts warn on reduced efficacy with shorter gap* Third wave of pandemic "appears to be broken" - minister (Recasts to lead on AstraZeneca shif...

Today 09:54

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

Today 09:49

Germany says production capacity, not patents, key to upping vaccine output

BERLIN, May 7 (Reuters) - The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany's health minister said Friday, reiterating Berlin's opposition to a U.S. proposal to waive pate...

Today 09:23

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.